期刊文献+

hLMO3基因全长及截短序列原核表达载体的构建及蛋白诱导表达

Construction of prokaryotic plasmid of human LMO3 and deletions gene and identification of their recombinant proteins
原文传递
导出
摘要 目的构建hLMO3原核全长及5个截短表达载体并鉴定融合蛋白的表达。方法提取工具细胞HEK293的mRNA,反转录为cDNA,PCR扩增hLMO3全长及截短编码基因,亚克隆至GST融合表达载体pGEX-5X-2中。在E.coli BL21中诱导GST-hLMO3全长及截短融合蛋白表达,并经免疫印迹鉴定结果。结果 hLMO3全长及5个截短基因序列克隆到了原核表达载体pGEX-5X-2中,并经测序鉴定正确。Westernblot在E.coli Bl21中检测到了相应融合蛋白的表达。结论成功构建hLMO3全长及5个截短基因序列原核表达载体,在E.coli BL21中诱导表达出GST-LMO3全长及截短融合蛋白。 Objective To construct an prokaryotic expression vector of LMO3(LIM-domain only 3) full-length and deletion gene and identify their recombinant protein expressions induced by isopro-pyl-1-thio-b-Dgalactopyranoside(IPTG).Methods Total RNA was extracted from HEK293,hLMO3 and deletion coding sequences were amplified by polymerase chain reaction(PCR)method and cloned into pGEX-5X-2.The expression of GST-hLMO3 fusion proteins was induced by IPTG and identified by Western blot.Results The coding sequence of hLMO3 full-length and deletion gene were cloned into the pGEX-5X-2 which was transformed into BL21 successfuly,and identified by double enzymes digestion and sequencing.The expression of GST-hLMO3 fusion proteins induced by IPTG was observed in Bl21.Conclusion The recombinant prokaryotic plasmids were constructed successfully into pGEX-5X-2 and the expression of GST-LMO3 full-length and deletion fusion proteins was identified.
出处 《解剖科学进展》 CAS 2012年第1期8-11,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金重大研究计划(No.90813038)
关键词 hLMO3 工具细胞HEK293 原核表达 截短蛋白 LIM-domain only 3 HEK293 prokaryotic expression deletions
  • 相关文献

参考文献14

  • 1Dawid IB,Breen JJ,Toyama R.LIM domains:multiple roles as adaptors and functional modifiers in protein interactions[J].Trends Genet,1998,14:156-62.
  • 2Sanchez-Garcia I,Rabbitts TH.The LIM domain:a new structural motif found in zinc-finger-like proteins[J].Trends Genet,1994,10:315-320.
  • 3Dawid IB,Toyama R,Taira M.LIM domain proteins[J].C RAcad Sci Ⅲ,1995,318:295-306.
  • 4Rabbitts TH.LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes[J].Genes Dev,1998,12:2651-2657.
  • 5Mineyoshi A,Toshinori O,Hiroyuki I,et al.LMO3 interacts with neuronal transcription factor,HEN2,and acts as an oncogene in neuroblastoma[J].Cancer Res,2005,65:4587-4597.
  • 6李彦姝,王春玉,苏楠,张红艳,李丹妮,李丰.hLMO4基因重组质粒的构建及蛋白表达和定位[J].解剖科学进展,2009,15(1):85-87. 被引量:4
  • 7Milan M,Cohen SM.Regulation of LIM homeodomain activity in vivo:A tetramer of dLDB and apterous confers activity and capacity for regulation by dLMO[J].Mol Cell,1999,4(2):267-273.
  • 8Matthews JM,Bhati M,Craiq VJ,et al.Competition between LIM binding domains[J].Biochem Soc Trans,2008,36 (6):1393-1397.
  • 9McGuire EA,Rintoul CE,Sclar GM,Korsmeyer SJ.Thymic overex pression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma[J].Mol Cell Biol,1992,12:4186-4196.
  • 10Fisch P,Boehm T,Lavenir I,et al.T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes[J].Oncogene,1992,7:2389-2397.

二级参考文献6

  • 1Curtiss J, Heilig JS. DeLIMiting development [J]. Bioessays, 1998, 20(1): 58-69.
  • 2Freyd G, Kim SK, Horvitz HR. Novel eysteine-fich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11 [J]. Nature, 1990, 344(6269): 879 - 882.
  • 3Grutz GG, Bucher K, Lavenir, Lavenir I, et al.The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells[J]. EMBO, 1998, 17: 4594-4605.
  • 4Sum EY, Peng B, Yu X, et al. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity [J]. J Biol Chem,2002, 277(10): 7849- 7856.
  • 5Aoyama M, Ozaki T, Inuzuka H, et al. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma[J]. Cancer Res, 2005, 65(11): 4587--4597.
  • 6Sum EY, Segara D, Duscio B, et al. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer[J]. Proc Natl Acad Sci, 2005, 102(21): 7659-7664.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部